179 related articles for article (PubMed ID: 15070922)
1. Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls.
McLaughlin T; Abbasi F; Lamendola C; Frayo RS; Cummings DE
J Clin Endocrinol Metab; 2004 Apr; 89(4):1630-5. PubMed ID: 15070922
[TBL] [Abstract][Full Text] [Related]
2. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
[TBL] [Abstract][Full Text] [Related]
3. The associations between plasma adiponectin, ghrelin levels and cardiovascular risk factors.
Choi KM; Lee J; Lee KW; Seo JA; Oh JH; Kim SG; Kim NH; Choi DS; Baik SH
Eur J Endocrinol; 2004 May; 150(5):715-8. PubMed ID: 15132729
[TBL] [Abstract][Full Text] [Related]
4. Regulation of ghrelin is related to estimated insulin sensitivity in obese children.
Krohn K; Boczan C; Otto B; Heldwein W; Landgraf R; Bauer CP; Koletzko B
Int J Obes (Lond); 2006 Oct; 30(10):1482-7. PubMed ID: 16801928
[TBL] [Abstract][Full Text] [Related]
5. Plasma ghrelin levels after two high-carbohydrate meals producing different insulin responses in patients with metabolic syndrome.
Heinonen MV; Karhunen LJ; Chabot ED; Toppinen LK; Juntunen KS; Laaksonen DE; Siloaho M; Liukkonen KH; Herzig KH; Niskanen LK; Mykkänen HM
Regul Pept; 2007 Feb; 138(2-3):118-25. PubMed ID: 17030069
[TBL] [Abstract][Full Text] [Related]
6. Low ghrelin concentrations in nonalcoholic fatty liver disease are related to insulin resistance.
Marchesini G; Pagotto U; Bugianesi E; De Iasio R; Manini R; Vanni E; Pasquali R; Melchionda N; Rizzetto M
J Clin Endocrinol Metab; 2003 Dec; 88(12):5674-9. PubMed ID: 14671152
[TBL] [Abstract][Full Text] [Related]
7. Plasma ghrelin in obesity before and after weight loss after laparoscopical adjustable gastric banding.
Hanusch-Enserer U; Cauza E; Brabant G; Dunky A; Rosen H; Pacini G; Tüchler H; Prager R; Roden M
J Clin Endocrinol Metab; 2004 Jul; 89(7):3352-8. PubMed ID: 15240614
[TBL] [Abstract][Full Text] [Related]
8. Circulating obestatin levels and the ghrelin/obestatin ratio in obese women.
Vicennati V; Genghini S; De Iasio R; Pasqui F; Pagotto U; Pasquali R
Eur J Endocrinol; 2007 Sep; 157(3):295-301. PubMed ID: 17766711
[TBL] [Abstract][Full Text] [Related]
9. Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels.
Pagotto U; Gambineri A; Vicennati V; Heiman ML; Tschöp M; Pasquali R
J Clin Endocrinol Metab; 2002 Dec; 87(12):5625-9. PubMed ID: 12466363
[TBL] [Abstract][Full Text] [Related]
10. The satiating effect of dietary protein is unrelated to postprandial ghrelin secretion.
Moran LJ; Luscombe-Marsh ND; Noakes M; Wittert GA; Keogh JB; Clifton PM
J Clin Endocrinol Metab; 2005 Sep; 90(9):5205-11. PubMed ID: 16014402
[TBL] [Abstract][Full Text] [Related]
11. Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin.
Korner J; Bessler M; Cirilo LJ; Conwell IM; Daud A; Restuccia NL; Wardlaw SL
J Clin Endocrinol Metab; 2005 Jan; 90(1):359-65. PubMed ID: 15483088
[TBL] [Abstract][Full Text] [Related]
12. Acute insulin infusion decreases plasma ghrelin levels in uncomplicated obesity.
Leonetti F; Iacobellis G; Ribaudo MC; Zappaterreno A; Tiberti C; Iannucci CV; Vecci E; Di Mario U
Regul Pept; 2004 Nov; 122(3):179-83. PubMed ID: 15491789
[TBL] [Abstract][Full Text] [Related]
13. Association of acylated and nonacylated ghrelin with insulin sensitivity in overweight and obese postmenopausal women.
St-Pierre DH; Karelis AD; Coderre L; Malita F; Fontaine J; Mignault D; Brochu M; Bastard JP; Cianflone K; Doucet E; Imbeault P; Rabasa-Lhoret R
J Clin Endocrinol Metab; 2007 Jan; 92(1):264-9. PubMed ID: 17062757
[TBL] [Abstract][Full Text] [Related]
14. Ghrelin and obestatin levels in hypertensive obese patients.
Wang WM; Li SM; Du FM; Zhu ZC; Zhang JC; Li YX
J Int Med Res; 2014 Dec; 42(6):1202-8. PubMed ID: 25186095
[TBL] [Abstract][Full Text] [Related]
15. Fasting plasma ghrelin levels are negatively correlated with insulin resistance and PAI-1, but not with leptin, in obese children and adolescents.
Ikezaki A; Hosoda H; Ito K; Iwama S; Miura N; Matsuoka H; Kondo C; Kojima M; Kangawa K; Sugihara S
Diabetes; 2002 Dec; 51(12):3408-11. PubMed ID: 12453893
[TBL] [Abstract][Full Text] [Related]
16. The relationship between active ghrelin levels and human obesity involves alterations in resting energy expenditure.
Marzullo P; Verti B; Savia G; Walker GE; Guzzaloni G; Tagliaferri M; Di Blasio A; Liuzzi A
J Clin Endocrinol Metab; 2004 Feb; 89(2):936-9. PubMed ID: 14764817
[TBL] [Abstract][Full Text] [Related]
17. Fasting and postprandial hyperghrelinemia in Prader-Willi syndrome is partially explained by hypoinsulinemia, and is not due to peptide YY3-36 deficiency or seen in hypothalamic obesity due to craniopharyngioma.
Goldstone AP; Patterson M; Kalingag N; Ghatei MA; Brynes AE; Bloom SR; Grossman AB; Korbonits M
J Clin Endocrinol Metab; 2005 May; 90(5):2681-90. PubMed ID: 15687345
[TBL] [Abstract][Full Text] [Related]
18. Circulating levels of active ghrelin is associated with abdominal adiposity, hyperinsulinemia and insulin resistance in patients with type 2 diabetes mellitus.
Katsuki A; Urakawa H; Gabazza EC; Murashima S; Nakatani K; Togashi K; Yano Y; Adachi Y; Sumida Y
Eur J Endocrinol; 2004 Nov; 151(5):573-7. PubMed ID: 15538935
[TBL] [Abstract][Full Text] [Related]
19. Maintenance of a normal meal-induced decrease in plasma ghrelin levels in children with Prader-Willi syndrome.
Bizzarri C; Rigamonti AE; Giannone G; Berardinelli R; Cella SG; Cappa M; Müller EE
Horm Metab Res; 2004 Mar; 36(3):164-9. PubMed ID: 15057669
[TBL] [Abstract][Full Text] [Related]
20. Oral glucose load inhibits circulating ghrelin levels to the same extent in normal and obese children.
Baldelli R; Bellone S; Castellino N; Petri A; Rapa A; Vivenza D; Bellone J; Broglio F; Ghigo E; Bona G
Clin Endocrinol (Oxf); 2006 Mar; 64(3):255-9. PubMed ID: 16487433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
